Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1966 Aug 1;124(2):227–240. doi: 10.1084/jem.124.2.227

STUDIES ON THE EFFECT OF EXPERIMENTAL NONKETOTIC DIABETES MELLITUS ON ANTIBACTERIAL DEFENSE

I. DEMONSTRATION OF A DEFECT IN PHAGOCYTOSIS

Robert H Drachman 1, Richard K Root 1, W Barry Wood Jr 1
PMCID: PMC2180468  PMID: 4380670

Abstract

Chronically diabetic nonketotic rats were shown to be more susceptible to experimental Type 25 pneumococcal pneumonia than nondiabetic rats. The cumulative mortality in the diabetic group was significantly higher at infecting doses of 103, 104, 105, and 106 organisms, and the LD 50 was less than one twentieth of that for the nondiabetic group. More than ten times as many viable pneumococci were found in the pneumonic lesions of the diabetic animals at 24 and 36 hr as were present in the lesions of the nondiabetic controls, and serial histologic studies revealed that phagocytosis was strikingly depressed in the alveolar exudates of the diabetic animals. The diabetic state was also found to cause a similar depression of in vivo phagocytosis in preformed peritoneal exudates. The results of in vitro experiments indicated that the principal defect in the diabetic animals resided in their serum rather than in their polymorphonuclear leukocytes. The depressive factor in the serum was identified as the abnormally high concentration of glucose. Since equivalent molar concentrations of unmetabolized sugars added to normal serum caused a similar depression of phagocytosis, it was tentatively concluded that the action of the glucose on the leukocytes was primarily osmotic. The sensitivity of the granulocytes to the glucose effect, however, depended upon the conditions of the phagocytic test. Only when the pneumococci were encapsulated and the leukocytes derived from inflammatory exudates were crowded together, as in vivo, was the depressive action of the glucose clearly demonstrable.

Full Text

The Full Text of this article is available as a PDF (872.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROWN W. F. VARIANCE ESTIMATION IN THE REED-MUENCH FIFTY PER CENT END-POINT DETERMINATION. Am J Hyg. 1964 Jan;79:37–46. doi: 10.1093/oxfordjournals.aje.a120362. [DOI] [PubMed] [Google Scholar]
  2. BYBEE J. D., ROGERS D. E. THE PHAGOCYTIC ACTIVITY OF POLYMORPHONUCLEAR LEUKOCYTES OBTAINED FROM PATIENTS WITH DIABETES MELLITUS. J Lab Clin Med. 1964 Jul;64:1–13. [PubMed] [Google Scholar]
  3. Briscoe H. F., Allison F., Jr Diabetes and host resistance. I. Effect of alloxan diabetes upon the phagocytic and bactericidal efficiency of rat leukocytes for Pneumococcus. J Bacteriol. 1965 Dec;90(6):1537–1541. doi: 10.1128/jb.90.6.1537-1541.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CHERNEW I., BRAUDE A. I. Depression of phagocytosis by solutes in concentrations found in the kidney and urine. J Clin Invest. 1962 Oct;41:1945–1953. doi: 10.1172/JCI104652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. COHN Z. A., MORSE S. I. Interactions between rabbit polymorphonuclear leucocytes and staphylococci. J Exp Med. 1959 Sep 1;110:419–443. doi: 10.1084/jem.110.3.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. KARNOVSKY M. L. Metabolic basis of phagocytic activity. Physiol Rev. 1962 Jan;42:143–168. doi: 10.1152/physrev.1962.42.1.143. [DOI] [PubMed] [Google Scholar]
  7. KASS E. H. Hormones and host resistance to infection. Bacteriol Rev. 1960 Mar;24(1):177–185. doi: 10.1128/br.24.1.177-185.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. MARTIN S. P., McKINNEY G. R., GREEN R., BECKER C. The influence of glucose, fructose, and insulin on the metabolism of leukocytes of healthy and diabetic subjects. J Clin Invest. 1953 Nov;32(11):1171–1174. doi: 10.1172/JCI102841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. PERILLIE P. E., NOLAN J. P., FINCH S. C. Studies of the resistance to infection in diabetes mellitus: local exudative cellular response. J Lab Clin Med. 1962 Jun;59:1008–1015. [PubMed] [Google Scholar]
  10. SBARRA A. J., SHIRLEY W., BAUMSTARK J. S. Effect of osmolarity on phagocytosis. J Bacteriol. 1963 Feb;85:306–313. doi: 10.1128/jb.85.2.306-313.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. SHELDON W. H., BAUER H. The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits. J Exp Med. 1959 Dec 1;110:845–852. doi: 10.1084/jem.110.6.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. SMITH M. R., WOOD W. B., Jr Surface phagocytosis; further evidence of its destructive action upon fully encapsulated pneumococci in the absence of type-specific antibody. J Exp Med. 1958 Jan 1;107(1):1–12. doi: 10.1084/jem.107.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SPIRO R. G., HASTINGS A. B. Studies on carbohydrate metabolism in rat liver slices. XI. Effect of prolonged insulin administration to the alloxan-diabetic animal. J Biol Chem. 1958 Feb;230(2):751–759. [PubMed] [Google Scholar]
  14. WERTMAN K. F., HENNEY M. R. The effects of alloxan diabetes on phagocytosis and susceptibility to infection. J Immunol. 1962 Sep;89:314–317. [PubMed] [Google Scholar]
  15. Wood W. B. STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : I. THE ACTION OF TYPE SPECIFIC ANTIBODY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA. J Exp Med. 1941 Jan 31;73(2):201–222. doi: 10.1084/jem.73.2.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wood W. B., Smith M. R., Watson B. STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : IV. THE MECHANISM OF PHAGOCYTOSIS IN THE ABSENCE OF ANTIBODY. J Exp Med. 1946 Sep 30;84(4):387–402. doi: 10.1084/jem.84.4.387. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES